Jessie J, who shared her breast cancer diagnosis in June and underwent surgery this summer, said she's been "crying a lot" as ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

An international team of researchers has discovered a new method to fight cancers that no longer respond to treatment.

Using cancer’s own survival tricks against it, scientists may have found a new way to stay one step ahead of the disease.

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.